Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Obstetrics Surgery
  •  Cardiovascular Surgery
  •  Minimally Invasive Surgery
  •  Gastroenterological Surgery
  •  Otolaryngology - Head and Neck Surgery
  •  Vascular Surgery
  •  Pediatric Surgery
  •  Thoracic Surgery


Citation: Clin Surg. 2019;4(1):2360.Research Article | Open Access

Surgical Outcomes of Pulmonary Lobectomies for Malignant Diseases: Experience of a Moroccan Center about 42 Cases

Harmouchi H, Lakranbi M,, Issoufou I1,, Belliraj L, Ammor FZ, Rabiou S, Ouadnouni Y, and Smahi M,

Department of Thoracic Surgery, CHU Hassan II of Fez-Morocco, Morocco
Department of Medicine and Pharmacy, Sidi Mohamed Ben Abdallah University, Morocco

*Correspondance to: Harmouchi H 

 PDF  Full Text DOI: 10.25107/2474-1647.2360


Introduction: Pulmonary lobectomy is an anatomical resection of lung which presents the basic treatment for malignant diseases, particularly for non-small cell lung cancer. In this study we present our experience in the management of these diseases operated by lobectomy, including our surgical habits, morbidity and mortality results. Material and
Methods: It was a monocentric and retrospective study including 42 patients, all operated for a malignant disease by a lobectomy of lung, over 8 years.
Results: This study included 32 men and 10 women, with a median age of 54.95 years old. Chronic smoking was presented in 19 patients (45.23%), and 8 patients (19.04%) had a known neoplasia. Respiratory functional signs were predominated by hemoptysis in 13 patients (30.95%), and the discovery was accidental for 14 patients (33.33%). Respiratory functional exploration done by spirometry showed a mean FEV1 of 2.86 Liter. The approach was a posterolteral thoracotomy for all patients (100%), and surgical procedure was a lobectomy for all patients (100%). Histological study was predominated for non small cell lung cancer in 26 patients (61.9%). The average duration of hospitalization was 6 days, and the mean follow-up was 2.6 ans. The rate of morbidity and mortality in our study was respectively 14.28% and 7.14%.
Conclusion: Pulmonary lobectomy is performed in our department with an acceptable rate of morbidity and mortality, even if all patients were approached by thoracotomy.


Pulmonary lobectomy; Lung cancer; Surgery

Cite the article

Harmouchi H, Lakranbi M, Issoufou I, Belliraj L, Ammor FZ, Rabiou S, et al. Surgical Outcomes of Pulmonary Lobectomies for Malignant Diseases: Experience of a Moroccan Center about 42 Cases. Clin Surg. 2019; 4: 2360.

Search Our Journal

Journal Indexed In

Articles in PubMed

Risk Factors for Visual Impairment in an Uninsured Population and the Impact of the Affordable Care Act
 PubMed  PMC  PDF  Full Text
Monitoring an Ongoing Enhanced Recovery after Surgery (ERAS) Program: Adherence Improves Clinical Outcomes in a Comparison of Three Thousand Colorectal Cases
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Set Up New Cardiac Surgery Peri-Operative Service in a General Adult Intensive Care Unit during COVID-19 Pandemic
 Abstract  PDF  Full Text
Sclerotherapy with Polidocanol Foam is a Promising Perspective Treatment for Pyogenic Granuloma: A Retrospective Analysis in 52 Cases
 Abstract  PDF  Full Text
View More...